I 
117TH CONGRESS 
2D SESSION 
H. R. 6513 
To amend the Federal Food, Drug, and Cosmetic Act to exempt from 
regulation as devices non-invasive diagnostic devices, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 28, 2022 
Mr. BIGGS introduced the following bill; which was referred to the Committee 
on Energy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
exempt from regulation as devices non-invasive diagnostic 
devices, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Medical Innovation Ac-
4
celeration Act of 2022’’. 
5
SEC. 2. EXEMPTING NON-INVASIVE DIAGNOSTIC DEVICES 
6
FROM REGULATION AS DEVICES. 
7
Section 201(h) of the Federal Food, Drug, and Cos-
8
metic Act (21 U.S.C. 321(h)) is amended— 
9
VerDate Sep 11 2014 
22:49 Jan 28, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6513.IH
H6513
pbinns on DSKJLVW7X2PROD with BILLS
2 
•HR 6513 IH
(1) in the second sentence by inserting before 
1
the period at the end the following: ‘‘or any non- 
2
invasive diagnostic device’’; and 
3
(2) by adding at the end the following: ‘‘For 
4
purposes of the preceding sentence, the term ‘non- 
5
invasive’ means, with respect to a diagnostic device, 
6
that the device does not penetrate the skin or any 
7
other membrane of the body, is not inserted or im-
8
planted into the body, causes no more than ephem-
9
eral compression or temperature changes to in situ 
10
bodily tissues, and does not subject bodily tissues to 
11
ionizing radiation.’’. 
12
Æ 
VerDate Sep 11 2014 
22:49 Jan 28, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H6513.IH
H6513
pbinns on DSKJLVW7X2PROD with BILLS
